Citadel Advisors’s OnKure Therapeutics, Inc. Class A Common Stock OKUR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.6M | Buy |
1,089,310
+21,206
| +2% | +$50.7K | ﹤0.01% | 2449 |
|
|
2025
Q1 | $4.44M | Sell |
1,068,104
-6,210
| -0.6% | -$25.8K | ﹤0.01% | 1857 |
|
|
2024
Q4 | $8.78M | Buy |
1,074,314
+1,065,023
| +11,463% | +$8.71M | ﹤0.01% | 1404 |
|
|
2024
Q3 | $158K | Buy |
9,291
+8,200
| +752% | +$139K | ﹤0.01% | 4746 |
|
|
2024
Q2 | $16.5K | Sell |
1,091
-5,524
| -84% | -$83.4K | ﹤0.01% | 5445 |
|
|
2024
Q1 | $110K | Buy |
6,615
+5,648
| +584% | +$93.8K | ﹤0.01% | 5040 |
|
|
2023
Q4 | $15.5K | Sell |
967
-491
| -34% | -$7.85K | ﹤0.01% | 5443 |
|
|
2023
Q3 | $111K | Sell |
1,458
-1,594
| -52% | -$121K | ﹤0.01% | 4798 |
|
|
2023
Q2 | $200K | Buy |
+3,052
| New | +$200K | ﹤0.01% | 4457 |
|
|
2022
Q4 | – | Sell |
-14,615
| Closed | -$490K | – | 6830 |
|
|
2022
Q3 | $490K | Sell |
14,615
-2,644
| -15% | -$88.6K | ﹤0.01% | 4099 |
|
|
2022
Q2 | $457K | Buy |
+17,259
| New | +$457K | ﹤0.01% | 4228 |
|